Friedman, Lori

USPTO Trademark & Patent Filings

Friedman Lori

Trademark applications and grants for Friedman, Lori. Friedman, Lori has 2 trademark applications. The latest application filed is for "LOVE POLICY"

Company Profile
    Company Aliases
  • Friedman, Lori
  • lori friedman
  • Friedman; Lori - San Carlos CA
Entity Type INDIVIDUAL
Address 701 SE 21st Ave., #308 Deerfield Beach, FLORIDA UNITED STATES 33441

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
20180280408 - 15/897032 Belvin; Marcia ;   et al.
2018-10-04
METHODS OF TREATMENT WITH TASELISIB
20160375033 - 15/194859 Edgar; Kyle ;   et al.
2016-12-29
COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND A CDK4/6 INHIBITOR COMPOUND FOR THE TREATMENT OF CANCER
20160279142 - 15/080019 Friedman; Lori ;   et al.
2016-09-29
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
20160045515 - 14/791783 Belvin; Marcia ;   et al.
2016-02-18
METHODS OF TREATING PR-POSITIVE, LUMINAL A BREAST CANCER WITH PI3K INHIBITOR, PICTILISIB
20150335650 - 14/717069 Derynck; Mika K. ;   et al.
2015-11-26
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
10,004,748 - 14/717,069 Derynck , et al. June 26, 2
2018-06-26
Methods and compositions for modulating estrogen receptor mutants
9,855,270 - 14/645,578 Hager , et al. January 2, 2
2018-01-02
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
9,335,320 - 13/968,202 Ebens, Jr. , et al. May 10, 2
2016-05-10
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
9,107,926 - 13/912,281 Belvin , et al. August 18, 2
2015-08-18
SCDs as modifiers of the p53 pathway and methods of use
8,771,942 - 12/714,257 Belvin , et al. July 8, 2
2014-07-08
Patent Grants & Applications
Trademark Applications
Mark Image

Registration | Serial
Trademark
Application Date
 LOVE POLICY
"LOVE POLICY"
88775801
LOVE POLICY
2020-01-28
 I SELL LOVE
"I SELL LOVE"
88680372
I SELL LOVE
2019-11-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed